Tax Incentives
IDT is a Registered Research Agency with the Australian Industry Research and Development Board.
With pharmaceutical development projects taking significant time and investment, many IDT clients have used the R&D Tax Incentive Program to conduct R&D in a very cost-efficient manner.
IDT is a registered Research Service Provider, number 04563.
Our clients may be eligible for a refundable 43.5 cents* in the dollar cash tax rebate or a 38.5%* Tax Shield variable tax offset on eligible R&D activities undertaken by IDT.
A number of our overseas clients have also taken advantage of the R&D Tax Incentive Program scheme along with the CTN clinical trial notification scheme available in Australia to fast-track their development pathways, whilst claiming a generous tax benefit rebate* on their development costs.
This has helped a number of companies with their cashflow, especially where there is a tax refund.
*Rebate amounts are subject to change. Contact us at [email protected] to discover more about how your project can benefit from the R&D tax incentive scheme.